Skip to main content
Evidence Based Longevity (EBL)Check what I take
← All protocols
D

Protocol

Eating breakfast for weight control

In a 2019 meta-analysis A study that pools the numbers from several trials into one combined estimate., people assigned to eat breakfast weighed 0.44 kg more than people assigned to skip it across the 7 trials that measured weight, and ate about 260 more calories a day across the 10 that measured intake.

Grade D, tested: in a human randomized trial, the treated group did worse on the endpoint The outcome a trial measures to decide whether the treatment worked, such as heart attacks, blood pressure or a symptom score. graded. How to read a grade →

Compare this record with another, side by side →

At a glance

In plain words

People are often told that breakfast helps control weight. Trials tested this. In 7 trials that measured weight, people told to eat breakfast ended up about half a kilo heavier. In 10 trials, they ate about 260 more calories a day than people told to skip it. Later studies found the same. The trials were short, lasting weeks rather than years. People who skipped breakfast had higher LDL cholesterol.

The letter, taken apart
What was measured
Body weight in 7 trials and daily calorie intake in 10.
How big
Breakfast eaters weighed 0.44 kg more than skippers.Read from the summary of PMID PubMed ID: the permanent number the US National Library of Medicine gives a published paper. Each one links to that paper's record on PubMed. 30700403.
Who it applies to
Adults in high-income countries over weeks.
Safety
None identified.
The record in one view
Compared with
Skipping breakfast.
Certainty
Grade D, resting on: Meta-analysis of 13 randomized trials.
What would change this grade
Could rise to C with: Randomized trial of breakfast eating against skipping. Who: Adults with overweight. Measured: Body weight at 12 months. Length: At least 12 months.
Cost
No price recorded yet.
Sources
3 studies cited on this record, listed under Sources.
For clinicians
A one-page summary of this record that prints with a clinician's name and practice, folds to a plain-language patient handout, and gives a chart note to paste into the patient record: Printable summary and chart note.
Food
DSurrogate biomarker · Tested, harm found Grade D

In a 2019 meta-analysis, people assigned to eat breakfast weighed 0.44 kg more than people assigned to skip it across the 7 trials that measured weight, and ate about 260 more calories a day across the 10 that measured intake. Two later analyses of randomized trials found the same direction. The claim that breakfast helps weight control was tested and the trials went the other way, so the letter is D on Route 2 Human randomized trials have been run and did not show benefit on the stated outcome. One of the two routes to the lowest letter on EBL's scale., tested, harm found. The trials were short and at risk of bias.

Why this letter

Why this gradeGrade D, tested, harm found. The reasoning, and what the grade does not cover.
Why this grade

Grade D on Route 2 for weight control: tested, harm found. Randomized trials tested breakfast for weight, and breakfast eaters ended slightly heavier: 0.44 kg in the 7 weight trials pooled by Sievert et al., 2019 (PMID 30700403), with the same direction in two later analyses (Bonnet et al., 2020; PMID 32304359; Yu et al., 2023; PMID 38089630). Certainty is low: the trials were short, all were at some risk of bias, and the analyses share most of their trials.

WHAT THIS GRADE DOES NOT COVERbreakfast for blood sugar control, school performance or other uses; long-term weight; and LDL Low-density lipoprotein cholesterol, the cholesterol fraction most closely tied to plaque in the arteries. cholesterol, which was higher in people who skipped breakfast in two of the analyses (PMID 32304359, PMID 38089630).

A grade describes the human evidence for a named use. It is not advice, and it is not a judgment on any individual prescription. How the letters are decided →

Who responds: this record's trial reading reports no subgroup that identifies who responds.

Evidence notes: meta-analysis

Endpoint graded: Body weight and energy intake (surrogate)

Last reviewed: November 2026

Evidence wanted

The trial that would change this grade.

DesignRandomized trial of breakfast eating against skipping
PopulationAdults with overweight
EndpointBody weight at 12 months
DurationAt least 12 months

A positive trial of this shape would move this entry to C.

Why the current trials fall short

A long trial could show whether the short-term finding holds.

Clinical trials

ClinicalTrials.gov, the public registry run by the U.S. National Library of Medicine, lists studies that are recruiting volunteers. The link below searches it for Breakfast among studies recruiting now. EBL has no relationship with any listed study and receives no payment for this link.

Search recruiting studies of Breakfast on ClinicalTrials.gov

Dose, form and timing

What to track

None; the trials found breakfast eaters slightly heavier, not lighter.

Safety

Safety evidence, by strength

No safety data. Each caution on this record, sorted by what it rests on.

Documented in human studies
Cautions resting on what randomized trials or large studies found in people.

None recorded.

Suspected from case reports
Harms reported in individual patients or uncontrolled observations, not confirmed by a trial.

None recorded.

Mechanistic only
Cautions reasoned from how it works, with no human harm data behind them.

None recorded.

Population cautions
Groups in whom it has not been studied, so its safety there is unknown.

None recorded.

No safety data

No safety data: EBL has found no trial or report of harm for this record. That is an absence of evidence, not a finding of safety.

Grade history

How this letter has changedLatest: No. 475 · November 2026 · Corrected.
Grade history
No. 475 · November 2026 · Corrected
Eating breakfast for weight control: trial counts corrected, two later analyses added, and the D now marked tested, harm found

The record said 13 trials found the weight difference; 7 of the 13 measured weight and 10 measured calorie intake (Sievert et al., BMJ, 2019; PMID 30700403). Two later meta-analyses of randomized trials found the same direction: skipping breakfast lowered weight by 0.54 kg (Bonnet et al., Obesity, 2020; PMID 32304359) and by 0.66 kg (Yu et al., Front Endocrinol, 2023; PMID 38089630). The breakfast groups did worse on the endpoint the claim names, so under the written definition the D on Route 2 now carries the tested, harm found badge, at low certainty. The same two analyses found higher LDL cholesterol in people who skipped breakfast, which the record now states as outside this grade. The letter stays D. Read and signed off by the editor (Arnold Sandlow, D.C.).PMID 30700403 PMID 32304359 PMID 38089630

No. 449 · November 2026 · First graded
Eating breakfast for weight control enters the food section: Grade D

New record in the food section. A meta-analysis of 13 randomized trials found that people assigned to eat breakfast weighed slightly more (0.44 kg) and ate about 260 more calories a day than people assigned to skip it. The claim that breakfast helps weight control was tested and not supported, so the letter is D on Route 2. The trials were short and at risk of bias.PMID 30700403

Every change to a letter on this site is dated and published. The full evidence log →

Sources

How this record was checked
Citations
Every paper cited on this page is matched to its PubMed record on every build.
Retractions
None of these papers is retracted or under a journal expression of concern. PubMed is checked again on every build.
Read against the papers
November 2026. By the EBL editor, Arnold Sandlow, DC.
Outside review
Not yet done. No reviewer outside EBL has checked this record.

What each of these checks can and cannot show: evidence integrity.

The evidence, in fullThree papers, each linked to its PubMed record.
The evidence

Sievert et al. (BMJ, 2019; PMID 30700403): systematic review A review that searches for every study on a question using a method set in advance, then assesses them together. and meta-analysis of 13 randomized trials in adults in high-income countries, 7 measuring weight and 10 measuring energy intake; breakfast eaters weighed 0.44 kg more (95% CI 0.07 to 0.82, I2 43%) and ate 259.79 kcal/day more (95% CI 78.87 to 440.71, I2 80%) than skippers; all trials at high or unclear risk of bias in at least one domain; mean follow-up 7 weeks for weight and 2 weeks for energy intake. Bonnet et al. (Obesity, 2020; PMID 32304359): 7 randomized trials, 425 adults, average 8.6 weeks; skipping breakfast lowered body weight by 0.54 kg (95% CI -1.05 to -0.03) against eating it, did not change percent body fat, and raised LDL cholesterol in the 3 trials that reported it. Yu et al. (Frontiers in Endocrinology, 2023; PMID 38089630): 11 trials; skipping breakfast lowered body weight by 0.66 kg (95% CI -1.09 to -0.24) and raised LDL cholesterol by 9.89 mg/dL (95% CI 5.14 to 14.63). The three analyses pool largely the same trials, so they agree with each other rather than replicate independently.

How EBL searched for the trials (1 search)

The search that was run, what it returned, and what was left out and why, so the absence of evidence can be checked as well as its presence.

Searched PubMed in November 2026. 40 records screened, 2 eligible for the graded claim.
Query: breakfast[ti] AND (weight[tiab] OR "body mass"[tiab] OR obesity[tiab] OR "energy intake"[tiab]) AND (meta-analysis[pt] OR systematic review[pt] OR randomized controlled trial[pt]), published 2019 to 2026
The 40 most recent of 59 records were screened by title. Two meta-analyses of randomized trials of breakfast on weight were eligible and added (PMID 32304359, PMID 38089630); the rest were single-meal or appetite studies, protein-content comparisons, children, or observational Research that watches what people already do rather than assigning a treatment. It can show that two things travel together, not that one causes the other. reviews. The earlier search (November 2026) screened only the 20 most recent titles and missed both.
PubMed watch: does a new study change the grade? (nothing new)

No new paper matching the search behind this grade has been added to PubMed since November 2026.

Last run November 2026. A letter on EBL moves only after a logged review. A new paper never moves a letter by arriving: it is read, the answer is written here, and any change to the letter is published in the evidence log.

Disclosure

Educational use only · Not medical advice · EBL grades published human evidence and does not recommend treatment. Stopping a prescription is a decision for your physician.

Evidence Based Longevity, Inc. is owner-operated and edited by Arnold Sandlow, D.C., a California-licensed chiropractor. Evidence Based Longevity publishes in English only · Machine translations are not produced or reviewed by EBL for accuracy

© Evidence Based Longevity, Inc. All rights reserved

Medical disclaimer

These statements have not been evaluated by the Food and Drug Administration. Any grade on this page describes the strength of published human trial evidence in the populations studied. It is not a recommendation for any individual and is not medical advice. Starting, stopping or changing any supplement or medication is a decision for your physician.

Grades move when new trials publish. A free monthly email lists every grade EBL moved, with the reason and the trial behind it: the sign-up is on the Evidence Log →

Build 9b19d78, November 2026